A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in various forms of cancer, causing https://socialtechnet.com/story7552519/vhh-fragments-reactivate-p53-new-promising-pathway-for-tumor-management